AstraZeneca Pharma India (BOM:506820) Scaled Net Operating Assets : N/A (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AstraZeneca Pharma India's operating assets for the quarter that ended in Mar. 2024 was ₹5,543 Mil. AstraZeneca Pharma India's operating liabilities for the quarter that ended in Mar. 2024 was ₹3,615 Mil. AstraZeneca Pharma India's Total Assets for the quarter that ended in Dec. 2023 was ₹0 Mil. Therefore, AstraZeneca Pharma India's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was N/A.

AstraZeneca Pharma India Scaled Net Operating Assets Historical Data

The historical data trend for AstraZeneca Pharma India's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Scaled Net Operating Assets Chart

AstraZeneca Pharma India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.22

0.16

0.09

0.11

0.20

AstraZeneca Pharma India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of AstraZeneca Pharma India's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, AstraZeneca Pharma India's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AstraZeneca Pharma India's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca Pharma India's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where AstraZeneca Pharma India's Scaled Net Operating Assets falls into.

AstraZeneca Pharma India Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

AstraZeneca Pharma India's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(5543.088	-	3615.127)	/	9848.7
=	0.20

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10780.283	-	5237.195
=	5543.088

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3661.109	-	27.836	-	18.146
=	3615.127

AstraZeneca Pharma India's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(5543.088	-	3615.127)	/	0
=	N/A

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	10780.283	-	5237.195
=	5543.088

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	3661.109	-	27.836	-	18.146
=	3615.127

AstraZeneca Pharma India Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

AstraZeneca Pharma India (BOM:506820) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

ASTRAZEN:India

Address

Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045

Website

https://www.astrazeneca.com

AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines